386 related articles for article (PubMed ID: 32632387)
1. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
Maliakkal BJ
Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
[TBL] [Abstract][Full Text] [Related]
2. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
3. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
4. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
Majumdar A; Tsochatzis EA
Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295
[TBL] [Abstract][Full Text] [Related]
5. Approach to prevention of non-alcoholic fatty liver disease after liver transplantation.
Sharma P; Arora A
Transl Gastroenterol Hepatol; 2020; 5():51. PubMed ID: 33073046
[TBL] [Abstract][Full Text] [Related]
6. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
Khullar V; Dolganiuc A; Firpi RJ
World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
Patel YA; Berg CL; Moylan CA
Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
[TBL] [Abstract][Full Text] [Related]
8. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation.
Maiwall R; Gupta M
Transl Gastroenterol Hepatol; 2020; 5():18. PubMed ID: 32258522
[TBL] [Abstract][Full Text] [Related]
9. NASH After Liver Transplantation: Impact of Immunosuppression.
Taneja S; Roy A; Duseja A
J Clin Exp Hepatol; 2023; 13(5):835-840. PubMed ID: 37693259
[TBL] [Abstract][Full Text] [Related]
10. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
12. NAFLD and liver transplantation: Disease burden, current management and future challenges.
Burra P; Becchetti C; Germani G
JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
Villeret F; Dharancy S; Erard D; Abergel A; Barbier L; Besch C; Boillot O; Boudjema K; Coilly A; Conti F; Corpechot C; Duvoux C; Faitot F; Faure S; Francoz C; Giostra E; Gugenheim J; Hardwigsen J; Hilleret MN; Hiriart JB; Houssel-Debry P; Kamar N; Lassailly G; Latournerie M; Pageaux GP; Samuel D; Vanlemmens C; Saliba F; Dumortier J
Liver Int; 2022 Nov; 42(11):2428-2441. PubMed ID: 35924452
[TBL] [Abstract][Full Text] [Related]
14. Current status of liver transplantation for non-B non-C liver cirrhosis and hepatocellular carcinoma.
Nishio T; Ito T; Hata K; Taura K; Hatano E
Ann Gastroenterol Surg; 2023 Jan; 7(1):42-52. PubMed ID: 36643372
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
18. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians.
Choudhary NS; Dhampalwar S; Saraf N; Rastogi A; Bhangui P; Soin AS
J Clin Exp Hepatol; 2024; 14(2):101281. PubMed ID: 38076440
[TBL] [Abstract][Full Text] [Related]
20. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
